SG Americas Securities
PAHC icon

SG Americas Securities’s Phibro Animal Health PAHC Stock Holding History

SG Americas Securities’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Buy
6,905
+3,262
+90% +$138K ﹤0.01% 2766
2026
Q1 		$201K Sell
3,643
-10,275
-74% -$489K ﹤0.01% 2635
2025
Q4 		$520K Buy
13,918
+3,181
+30% +$129K ﹤0.01% 2469
2025
Q3 		$434K Buy
+10,737
New +$355K ﹤0.01% 2221
2025
Q2 		– Sell
-10,550
Closed -$225K – 3423
2025
Q1 		$225K Sell
10,550
-2,612
-20% -$58.4K ﹤0.01% 2448
2024
Q4 		$276K Buy
13,162
+906
+7% +$21K ﹤0.01% 1862
2024
Q3 		$276K Buy
+12,256
New +$237K ﹤0.01% 2226
2024
Q1 		– Sell
-10,414
Closed -$121K – 3311
2023
Q4 		$121K Buy
10,414
+547
+6% +$6.17K ﹤0.01% 2603
2023
Q3 		$126K Buy
+9,867
New +$140K ﹤0.01% 2639
2023
Q2 		– Sell
-13,142
Closed -$201K – 2946
2023
Q1 		$201K Buy
+13,142
New +$201K ﹤0.01% 2408
2022
Q2 		– Sell
-8,458
Closed -$169K – 3553
2022
Q1 		$169K Sell
8,458
-11,152
-57% -$225K ﹤0.01% 2509
2021
Q4 		$400K Sell
19,610
-1,388
-7% -$29.6K ﹤0.01% 2294
2021
Q3 		$452K Buy
+20,998
New +$505K ﹤0.01% 2598
2021
Q2 		– Sell
-6,173
Closed -$151K – 3138
2021
Q1 		$151K Sell
6,173
-3,656
-37% -$82.6K ﹤0.01% 2854
2020
Q4 		$191K Buy
+9,829
New +$181K ﹤0.01% 2655
2020
Q3 		– Sell
-11,013
Closed -$289K – 3254
2020
Q2 		$289K Buy
11,013
+4,056
+58% +$101K ﹤0.01% 2542
2020
Q1 		$168K Buy
+6,957
New +$170K ﹤0.01% 2630
2019
Q4 		– Sell
-84,110
Closed -$1.79M – 3396
2019
Q3 		$1.79M Buy
+84,110
New +$2.3M 0.01% 1028
2018
Q4 		– Sell
-3,990
Closed -$171K – 3243
2018
Q3 		$171K Sell
3,990
-2,688
-40% -$127K ﹤0.01% 2636
2018
Q2 		$308K Buy
+6,678
New +$296K ﹤0.01% 2340
2017
Q1 		– Sell
-3,914
Closed -$115K – 3493
2016
Q4 		$115K Buy
+3,914
New +$107K ﹤0.01% 2774

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SG Americas Securities's PAHC Position: Q2 2026 in Review

SG Americas Securities increased its Phibro Animal Health (PAHC) stake by 90% in Q2 2026, buying an estimated $138K and bringing the position to 6,905 shares worth $217K. The position accounts for ﹤0.01% of the portfolio, ranked #2766.

SG Americas Securities first reported a position in PAHC in Q4 2016 and has held it in 21 quarters since. The position peaked at $1.79M in Q3 2019. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • SG Americas Securities held 6,905 shares of Phibro Animal Health worth $217K as of Q2 2026.
  • SG Americas Securities bought 3,262 Phibro Animal Health shares in Q2 2026, an estimated $138K.
  • Phibro Animal Health made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2766 holding.
  • SG Americas Securities first reported a position in Phibro Animal Health in Q4 2016 and has held it in 21 quarters since.
  • SG Americas Securities's Phibro Animal Health position peaked at $1.79M in Q3 2019.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.